+1 (941) 951-0126

Search for:

Skip to content

About Us
Microbiome Biotherapeutics
- Human Microbiome
- MiNE™ Platform
Intellectual Property
Qi601: The World’s First Microplastic DETOX
Plastic and Humans
Research
- DARPA Research
- Qi601 Biofilm Shield™
FAQs
News
- In the News
- Press Releases
Contact

Nicholas T. Monsul, M.D., F.A.C.S.

Co-Founder and Chairman

Eva A. Berkes, M.D.

Co-Founder and Chief Scientific Officer

Peter Barton Hutt

Quorum Innovations

2068 Hawthorne Street
Sarasota, FL 34239
Mon - Fri | 8:30-5:00
+1 (941) 951-0126

About Us

Quorum Innovations is a pioneering biotherapeutics company dedicated to discovering, developing, and delivering innovative microbiome-derived biotherapeutics to physicians and patients.

With a deep understanding of the human microbiome’s critical role in health and disease—particularly in barrier defense and immune modulation—Quorum is at the forefront of the rapidly evolving field of microbiome biotherapeutics, harnessing nature’s own microbial allies to restore balance and protect against modern health challenges.

Navigation

Home
About Us
Microbiome Biotherapeutics
Intellectual Property
Qi601: The World’s First Microplastic Detox
Scientific Research and Discovery
News
Careers
Contact

© 2026 Quorum Innovations, All Rights Reserved.